MAM
Gulzar lightens up Luminous’s Diwali
MUMBAI: Luminous has launched a unique social campaign that celebrates a part of Diwali that we often forget to talk about. While most Diwali campaigns talk about spending and splurging, others talk about the display of lights and fireworks across the country. This campaign, however, goes away from the conventional routes.
In a refreshing move, Luminous teamed up with renowned poet, lyricist and legend Gulzar to remind a country lost in the frenzy of bright lights and fireworks that at the end of the day the one thing that matters more than any other is the light in a person’s heart. In his own inimitable style and distinctive voice, Gulzar has brought out the message that only through the true light in our hearts, can we bring hope and happiness to the lives around us.
About the inception of this campaign, Autumn Worldwide CEO Anusha Shetty said, “It’s not too often when a client asks to create a campaign that goes beyond products.”
Luminous Power Technologies marketing VP Sachin Bhalla added, “Luminous as a brand has been very deeply embedded in consumer lives over the last 30 years. With these enchanting words we are happy to give the #roshnidilki a new meaning.”
Watch the video:
Lyrics of the poem:
Jab roshni kam ho jaaye toh
Ummeed jagaa dete hain
Jab suraj doobne lagta hai
Hum dil jalaa lete hain
Zindagi roshni, zindagi noor bhi hai
Magar dil jalaane ka dastoor bhi hai
Bahot raat tak roshni karti hai
Agar dil mein choti si ummeed rakh do
Ujaalon se ghar bhar mehekne lagega
Hatheli pe roshan koi cheez rakh do
Galey lagne waalon ka dastoor bhi hai
Zindagi roshni, zindagi noor bhi hai
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
